A Study of PR2527 in Participants With Relapsed/Refractory Hematologic Malignancies
Conditions: Aggressive B-Cell Non-Hodgkin's Lymphoma; Aggressive B-Cell NHL; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Mantle Cell Lymphoma (MCL); Richter's Syndrome Intervention: Drug: PRT2527 Sponsor: Prelude Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Lymphoma | Research | Study